May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
15-lipoxygenase A Resident Protective Pathway in the Cornea Suppresses Inflammatory Neovascularization
Author Affiliations & Notes
  • A. J. Leedom
    Pharmacology, New York Medical College, Valhalla, New York
  • L. Bellner
    Pharmacology, New York Medical College, Valhalla, New York
  • R. J. Kemp
    Pharmacology, New York Medical College, Valhalla, New York
  • M. Dunn
    Pharmacology, New York Medical College, Valhalla, New York
  • M. L. Schwartzman
    Pharmacology, New York Medical College, Valhalla, New York
  • K. Gronert
    Pharmacology, New York Medical College, Valhalla, New York
  • Footnotes
    Commercial Relationships A.J. Leedom, None; L. Bellner, None; R.J. Kemp, None; M. Dunn, None; M.L. Schwartzman, None; K. Gronert, None.
  • Footnotes
    Support Supported in part by EY016136 HIGHWIRE EXLINK_ID="48:5:1695:1" VALUE="EY016136" TYPEGUESS="GEN" /HIGHWIRE , HL34300 (KG) and EY06513 (MLS)
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1695. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. J. Leedom, L. Bellner, R. J. Kemp, M. Dunn, M. L. Schwartzman, K. Gronert; 15-lipoxygenase A Resident Protective Pathway in the Cornea Suppresses Inflammatory Neovascularization. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1695.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: Execution of an acute inflammatory/reparative response in the cornea is essential to maintain vision. This vital response is regulated by balanced formation of chemical mediators, of which lipid autacoids hold a key role as inflammatory and immune modulators. We recently identified a lipid autacoid circuit in the cornea, 15-lipoxygenase, which generates anti-inflammatory signals including lipoxin A4 and docosahexaenoic acid-derived NPD1. We set out to investigate if this endogenous protective circuit has a role in suppressing inflammatory neovascularization in the cornea.

Methods:: A silk suture (8.0) was placed in the apex of the cornea of 15-LOX knockout mice and matched congenic controls for 7 days. Neovascularization was quantitated by vital microscopy and immuno-fluorescence using CD31 as an endothelial marker. Inflammation was assessed by measuring MPO activity as a quantitative PMN marker. Expression of 15-LOX, heme-oxygenase, and selected inflammatory markers was assessed by Western Blot and Real-Time PCR analyses. Lipid autacoid formation was analyzed by LC/MS/MS-based lipidomics employing a triple quadruple linear ion trap LC/MS/MS system.

Results:: Lipidomic analyses demonstrated significant formation of inflammatory and angiogenic eicosanoids, PGE2, 5-HETE, 15-HETE, 12-HETE, 12-HETrE. Moreover, docosahexaenoic acid-derived NPD1 was a prominent product in mouse corneas. In vivo deletion of 15-LOX, in Alox15-/- mice, correlated with a shift of the lipid autacoid profile towards predominant PGE2 formation and a loss of NPD1 formation, which was associated with a significant increase (2 fold) in neovascularization and neutrophils content in the cornea. Moreover, Alox15-/- mice demonstrated impaired induction of the cytoprotective heme-oxygenase system in macrophages and injured corneas.

Conclusions:: Collectively these results provide the first direct evidence for formation of potent lipid inflammatory/immune and angiogenic mediators in inflammatory neovascularization and demonstrate that the 15-LOX system has a key role in counter-regulating inflammation and suppressing neovascularization. These protective actions are in part mediated by regulating expression of the cytoprotective heme-oxygenase system. In view of the high expression of the 15-LOX pathway in human and mouse corneas, this protective circuit is a promising therapeutic target for limiting the sequelae of corneal injury.

Keywords: neovascularization • cornea: epithelium • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×